ÂÜÀòÂÒÂ×

Dr. Allen Heller is a physician-scientist with 25 years of experience in leadership roles in pharmaceutical research and development. He has held executive positions as Head of Clinical Pharmacology and Head of Preclinical Development for Bayer Pharmaceuticals in North America, as well as Global Head of Research and Development for Bayer’s Consumer Care Division. He holds an MD degree from Johns Hopkins University School of Medicine and a Master of Public Health degree from the University of Southern California. He completed internal medicine and neurology residencies at Brown University and the Harvard Longwood Neurology Program and fellowship training in clinical pharmacology at Harvard Medical School. Prior to Bayer, Dr. Heller was an attending neurologist and full-time academic faculty member in the Department of Neurology at Harvard Medical School, where he was the recipient of an NIH Teacher-Investigator Development Award. In 2010-11, while at Bayer, he was a visiting fellow in the Department of Statistics at Harvard with Professor Donald Rubin. He holds a part-time teaching appointment as Clinical Professor of Preventive Medicine at the University of Southern California Keck School of Medicine. He is the author of over 40 peer-reviewed publications related to neuroscience, clinical pharmacology, and clinical trials in multiple therapeutic areas.